Seeing Is Believing
Currently out of the existing stock ratings of Roger Song, 36 are a BUY (76.6%), 10 are a HOLD (21.28%), 1 are a SELL (2.13%).
Analyst Roger Song, currently employed at JEFFERIES, carries an average stock price target met ratio of 29.17% that have a potential upside of 30.37% achieved within 118 days.
Roger Song’s has documented 95 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NKTR, Nektar Therapeutics at 11-Apr-2025.
Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 4/11/2025. The price target of $2 was fulfilled within 59 days with a profit of $1.38 (222.58%) receiving and performance score of 37.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1
$0.7 (233.33%)
$4
1 years 10 months 8 days ago
(14-Aug-2023)
0/6 (0%)
$0.49 (96.08%)
Hold
$1
$0.7 (233.33%)
$4
1 years 10 months 11 days ago
(11-Aug-2023)
0/6 (0%)
$0.44 (78.57%)
Buy
$25
1 years 10 months 11 days ago
(11-Aug-2023)
0/4 (0%)
$18.48 (1258.95%)
Buy
$20
2 years 2 months 22 days ago
(31-Mar-2023)
1/3 (33.33%)
$14.51 (264.30%)
220
Buy
$27
3 years 1 months 3 days ago
(19-May-2022)
0/1 (0%)
$18.23 (207.87%)
Which stock is Roger Song is most bullish on?
Which stock is Roger Song is most reserved on?
What Year was the first public recommendation made by Roger Song?